MARCHIBRODA GROUP, LLC

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

$120K

Filings

Unique Clients

Active Period

2020–2025

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2025	—	3	1
2024	—	4	1
2023	—	4	1
2022	$45,000	4	1
2021	$75,000	4	1
2020	—	2	1

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
ALLIANCE FOR CELL THERAPY NOW	$120,000	21	2020–2025

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	17
SENATE	17
Natl Institutes of Health (NIH)	14
Health & Human Services, Dept of (HHS)	3

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	21
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	11
Budget/Appropriations	Budget/Appropriations	10

Bills Explicitly Cited (5)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 133116th Congress

Consolidated Appropriations Act, 2021

2020 · fourth_quarter · Client: ALLIANCE FOR CELL THERAPY NOW

Open original LDA filing ↗

Cited source text and reported amounts

HR 133 - FY 2021 Consolidated Appropriations Act

Client expense: — · Firm income: —

Matched citations: HR 133

H.R. 133116th Congress

Consolidated Appropriations Act, 2021

2020 · fourth_quarter · Client: ALLIANCE FOR CELL THERAPY NOW

Open original LDA filing ↗

Cited source text and reported amounts

HR 133 - FY 2021 Consolidated Appropriations Act

Client expense: — · Firm income: —

Matched citations: HR 133

H.R. 133116th Congress

Consolidated Appropriations Act, 2021

2020 · fourth_quarter · Client: ALLIANCE FOR CELL THERAPY NOW

Open original LDA filing ↗

Cited source text and reported amounts

HR 133 FY 2021 Consolidated Appropriations Act

Client expense: — · Firm income: —

Matched citations: HR 133

H.R. 133116th Congress

Consolidated Appropriations Act, 2021

2020 · fourth_quarter · Client: ALLIANCE FOR CELL THERAPY NOW

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 133 - Consolidated Appropriations Act 2021

Client expense: — · Firm income: —

Matched citations: H.R. 133

Show 1 more cited filings

H.R. 133116th Congress

Consolidated Appropriations Act, 2021

2020 · fourth_quarter · Client: ALLIANCE FOR CELL THERAPY NOW

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 133 - Consolidated Appropriations Act 2021

Client expense: — · Firm income: —

Matched citations: H.R. 133

Source: Senate LDA

MARCHIBRODA GROUP, LLC — Lobbying Disclosure | Poliscope